Medical Advisory Board

As we stand at the forefront of transformative change in the field of healthcare, I want to take a moment to share a personal vision and the promising potential that lies ahead, particularly in the area of Alzheimer's disease. With my extensive experience in business development and my background as a practitioner in Regenerative Functional Medicine, I am excited to lead our endeavors toward creating viable solutions that can profoundly impact the lives of countless individuals and their families.

Alzheimer's disease continues to be one of the most pressing challenges in our society, affecting millions and straining the healthcare system worldwide. However, I firmly believe that through innovative approaches in Smart Medicine to treat root causes, we can unlock new pathways to prevention, treatment, and ultimately, a solution. My experience in making a healthcare shift has equipped me with a deep understanding of market dynamics, regulatory landscapes, and the importance of patient-centered care.

Dr. George F. Moricz is a nationally recognized pioneer in Functional and Regenerative Medicine, known for helping patients reverse chronic symptoms, restore vitality, and optimize longevity through personalized, integrative care. With over two decades of medical expertise, Dr. Moricz serves as a driving force behind our advanced care protocols at Alzheimer's Treatment Centers of America. Dr. Moricz received his medical degree from the University of Massachusetts Medical School and holds an undergraduate degree in Biology from Boston College. He began his clinical career in pelvic surgery and infertility, but his relentless curiosity and passion for patient-centered outcomes led him to expand his scope into hormone optimization, medical bariatrics, anti-aging medicine, and energy-based therapies. As the founder of the Youthful Blueprint System™, Dr. Moricz has treated patients from across the U.S. and abroad through concierge-style programs designed to uncover root causes and deliver customized treatment pathways. His innovations span natural sleep systems, nano-energetic formulations, and hormonal protocols that have redefined how longevity and healthspan are pursued.

James N. Goldenberg, MD, FAAN, is a Board-Certified Neurologist who practiced in Palm Beach County, Florida for over 25 years. He previously served as Chief Strategy Officer of NIRA Medical, a national neurology practice platform and as Chief Medical Officer for Headlands Research, a multinational integrated clinical trial network. Dr. Goldenberg cofounded the JEM Research Institute, a clinical trial site that has helped improve lives by advancing innovative medical therapies across therapeutic areas with a focus on memory disorders. He previously served as Medical Director for Atlantic Coast Health Network, a regional super Clinically Integrated Network (CIN) affiliated with the fifth largest public health system in the US, representing over 1,900 physicians and 200,000 lives in South Florida. In that role, he was responsible for strategy, value-based care initiatives, population health, clinical oversight, and patient safety. Dr. Goldenberg also served as President and Chairman of the Board of Medical Specialists of the Palm Beaches, a large multispecialty clinic with over 80 physicians serving Palm Beach County. His undergraduate training is in psychology from the University of Florida. He received his Medical Degree from the University of South Florida. His neurology training and fellowship in neuromuscular disease were completed at the University of Miami. Dr. Goldenberg has served JFK Hospital in Atlantis, Florida in multiple leadership roles including Chairman of the Board of Trustees and was the founding Medical Director of JFK Hospital's stroke program and helped develop their Comprehensive Stroke Center.

Ketul Patel, MD, FHM, FACP, is a board-certified Internal Medicine physician specializing in hospital medicine, acute care, and case management. He has nearly two decades of leadership, academic, and clinical experience spanning major health systems. Compassionate physician dedicated to Hospital Medicine, patient care, and support through every stage of health with a keen interest in preventative medicine and slowing mental decline.

• BS Biochemistry and Genetics — Texas A&M University
• MD — University of Texas Health San Antonio, Long School of Medicine
• Internal Medicine Residency — Mt. Sinai Beth Israel
• Six Sigma Green Belt

Dr. Douglas Davis is a dedicated adult neurologist with over a decade of experience in treating Alzheimer's disease. He is currently practicing in Salina, Kansas. Originally from Colorado, Dr. Davis completed his neurology residency at the University of South Carolina in Columbia. Passionate about advancing Alzheimer's care and prevention, he is actively involved in raising awareness for the disease in his community and across the country. Dr. Davis is married, has four children, and enjoys attending sporting events, concerts, and spending time with their two Presa Canarios.

Dr. Jonas Hylton is a seasoned executive with more than 20 years of global leadership in medical affairs, clinical development, and product commercialization across biotechnology and pharmaceutical sectors. He is currently the Vice President of Medical/Scientific Affairs and founder of Executive Biotech Advisors. Dr. Hylton is enthusiastic to serve on the Medical Advisory Board for the Alzheimer's Treatment Centers of America, where he brings his deep expertise in complex diseases, cross-functional strategy, clinical research and drug development to a mission that places patients and families at the center of care.

“The Alzheimer's Treatment Centers of America is leading a new era in cognitive care by bringing together science, humanity, and urgency,” said Dr. Hylton. “I joined this mission because it's not just about treating a disease. It's about restoring dignity, preserving connection, and standing with families on the front lines of one of the most personal healthcare challenges of our time.”

Dr. Beatriz Korc-Grodzicki specializes in Geriatric Medicine, with a special focus on Alzheimer's Disease, Preventive Medicine and Cancer in the Elderly. She practices primarily in New York, NY, and was affiliated with Memorial Sloan Kettering Cancer Center. Dr. Korc-Grodzicki graduated from Uruguay in 1983, and completed her training at Univ Rochester Med Ctr and Univ Rochester Med Ctr. She is board certified in Internal Medicine and Geriatric Medicine.

Founder of a Geriatric Service within the Department of Medicine in a Cancer Center providing geriatric care, risk assessment and transitions of care for older cancer patients during cancer treatment.

Provided geriatric longitudinal care in the outpatient and inpatient setting. Developed the Mobile Acute Care of the Elder (MACE) team for inpatient care of the frail older adult.

Experienced emergency medicine regional director and multiple department director with repeated success improving emergency department operational efficiency, team development, profits and hospital goal alignment. Utilizing predictive analytics, evidence-based practice and transformational leadership, success was attained in every medical directorship as objectively evidenced by decreased patient wait times, decreased left without being seen, and improved patient satisfaction. In addition, each site had increased profitability through volume growth, decreased personnel requirements and improved revenue management. Clinical and leadership experience at all levels and environments of emergency and critical care from large, urban level 1 trauma center to small, rural community hospitals.

• University of Mississippi School of Medicine — Doctor of Medicine (M.D.), Medicine, 1996–2000
• United States Military Academy at West Point — Bachelor of Science (B.S.), Mechanical Engineering, 1986–1990

Dr. Daniel Orcutt is a retired orthopedic surgeon and former Chair of a large orthopedic practice in Georgia, where he specialized in complex shoulder surgery and guided more than a thousand patients through successful recovery. With over 20 years of clinical leadership, he combines deep medical expertise with a practical understanding of the challenges patients face before and after surgery.

Today, Dr. Orcutt applies that experience as an entrepreneur and educator, building digital health tools, supplements, and online programs that simplify recovery and empower patients worldwide. His YouTube channel, Rotator Cuff Expert, has reached millions of viewers seeking clarity on shoulder surgery and rehabilitation.

At ATCA, Dr. Orcutt contributes both his medical perspective and his entrepreneurial insights to help shape patient-centered solutions that address the intersection of surgery, recovery, and long-term health.

Constantine (Dean) Georgiades, PhD, brings over 25 years of distinguished experience in research and development, quality operations, and regulatory compliance across consumer goods, pharmaceuticals, medical devices, biologicals, and innovative therapies, including cell therapy and combination products. His proven leadership in major biotechnology and pharmaceutical organizations, such as Bristol-Myers Squibb, Merck, and Johnson & Johnson, underscores his ability to drive operational excellence, ensure patient safety, and deliver impactful new products. At Bristol-Myers Squibb, Dr. Georgiades pioneered an ISO 22301-compliant Business Continuity Management strategy, safeguarding critical GxP processes during global crises, including the COVID-19 pandemic. At Merck, he led quality assurance strategies that supported key approvals for companion diagnostics in major cancer therapies. Earlier, at Johnson & Johnson, he managed quality operations, laboratories, and product development, contributing to over $1 billion in sales. Dr. Georgiades holds a PhD in Food Science/Chemistry from Rutgers University and is recognized for his contributions to the life sciences industry through numerous awards for research and innovation. His appointment strengthens ATCA's leadership as it continues to pioneer cutting-edge solutions for patients and families affected by Alzheimer's and related conditions.

Dr. Awender obtained her Bachelor's and Master's degrees from Northern Illinois University in DeKalb, and her Doctorate of Audiology degree from the University of Florida in Gainesville. During her 32 years in clinical practice, she has accumulated invaluable experience in driving business growth, operational excellence, and organizational success. Early in her career, Dr. Awender provided inpatient and outpatient services to more than 36,000 beneficiaries, including active military personnel, retirees, and family members, at General Leonard Wood Army Community Hospital in Fort Leonard Wood, Missouri. She then designed and established one of the first newborn hearing screening programs in Illinois at OSF St. Francis Medical Center in Peoria, the largest hospital in central Illinois, covering a 26-county region. Dr. Awender was actively involved in all aspects of implementation, including staff training and physician education; data collection and tracking; and outcome monitoring and follow-up review.

Dr. Ashish R. Thakakr, MD is an allopathically trained Internist, Pulmonologist and Intensive Care Physician. He is originally from Long Island, NY but relocated to South Florida for the sun, sand and healthier lifestyle. Since practicing Pulmonology he has begun to take a keen interest in the “total body” theory of disease, particularly respiratory disorders. He believes that the root cause of many pulmonary diseases may extend beyond the airways and have a multitude of contributing factors such as lifestyle, diet and exposure risks. In the same vein he has also begun to see that perhaps undertreated or uncontrolled pulmonary disorders, such as obstructive sleep apnea or COPD may also contribute to the detriment of diseases that are originally thought to affect other body systems, such as the central nervous system. It is with this hypothesis of interconnected disease processes that the holistic approach of The Alzheimer's Treatment Centers of America resonated with him loudest. He is excited to be part of the medical advisory board of ATCA and looks forward to seeing patients improve under their care.

Dr. Nizar Wehbi was appointed to serve as North Dakota's State Health Officer, effective May 1st, 2021 by Gov. Doug Burgum. Prior to his appointment, Dr. Wehbi served as Deputy Director of the Center for Health Policy and Assistant Professor at the University of Nebraska Medical Center (UNMC) in Omaha. As the Center for Health Policy's Deputy Director, Wehbi conducted research and policy analysis to inform policymaking with a focus on improving population health and the efficiency and effectiveness of the U.S. healthcare system. In that role, he led initiatives to address binge drinking and colorectal cancer and conducted analysis on the healthcare workforce shortage.

As an assistant professor in the College of Public Health at UNMC, Wehbi directed the Master's in Health Administration (MHA) program, with teaching areas of focus that include health administration, health policy, the U.S. healthcare system and human resources management. He also co-led a university-wide faculty leadership program.

In addition to his medical degree, Dr. Wehbi has a master's degree in public health and an MBA from the University of Nebraska. He also holds a graduate certificate in quality, patient safety and outcomes research from the Johns Hopkins Bloomberg School of Public Health.

Dr. Jonathan Artz is participating in the allopathic protocols/pathways of ATCA.

• Stanford University School of Business (Executive Education) — LEADERSHIP Program in Corporate Innovation, 1.5-Year On-Line Program (Certification, June 2023)
• Fellowship in Neurophysiology / EMG / Neuromuscular Disorders — UPMC (Presbyterian Hospital), University of Pittsburgh School of Medicine, 07/1998 – 06/1999
• Fellowship in Neurophysiology / EEG / Epilepsy — The University of Virginia (Charlottesville), 07/1997 – 06/1998
• Neurology Residency — UNC-Chapel Hill, 07/1994 – 06/1997
• Internship, Internal Medicine — UNC-Chapel Hill, 07/1993 – 06/1994
• Medical School — Emory University School of Medicine, 07/1989 – 05/1993
• Undergraduate College — Union, NY, 07/1985 – 06/1989, B.S. Biological Sciences; Phi Beta Kappa, Sigma Xi, Magna Cum Laude, Highest Honors in Biology

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. Maura Cohen, a Clinical Psychologist, has joined the Medical Advisory Board.

Dr. Cohen completed her Doctorate plus a 1-year Post-doc in Psychoanalytic Study at Nova Southeastern University in Fort Lauderdale, Florida in 1999 and her Shamanic study through the Four Winds Institute in 2007. Both the Psychoanalytic and Shamanic teacher lineages have imprinted her conceptualization and treatment of patients. She completed her B.A. in American Studies at Tulane University in New Orleans, including junior year abroad at University of Paris IV — La Sorbonne. She served as managing editor of the American Psychological Association's quarterly journal: Psychotherapy: Theory, Research, Practice and Training. She brings a wide lens to her practice focus on the Depressive and Anxiety Disorders, Trauma, Grief, and Couples Therapy as well as her sub-specialty of Therapy with Professional Athletes (Tennis and Equine Sports: Hunter-Jumper). The practice now offers Entheogenic Therapies including Ketamine-Assisted Psychotherapy to address treatment-resistant depression and other conditions calling for profound and immediate psychological effect.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. David Wexler, a renowned Psychiatrist, has joined the Medical Advisory Board.

With more than three decades of professional experience, Dr. Wexler has held a variety of roles in the mental health field. His expertise is in biological psychiatry and psychopharmacology.

Dr. Wexler has worked as a private practitioner, staff psychiatrist (inpatient and outpatient) in a number of healthcare systems nationally and internationally, Director of Consultation/Liaison Services, team psychiatrist for an NFL franchise, physician wellness psychiatrist for a large managed care consortium, and as director of a university teaching hospital's psychopharmacology clinic. He prides himself on remaining state-of-the-science, has held academic positions at several medical schools, and has served as a web-based psychiatric consultant for primary care physicians and other medical specialists.

Dr. Wexler emphasizes collaboration with a patient's treatment team, including his or her therapist, primary care physician, and other involved specialists. This, he believes, is paramount to optimizing the quality of healthcare and, in turn, the treatment outcome.

“I'm committed to delivering a highly therapeutic clinical experience through in-person visits as well as telemedicine.” — Dr. David B. Wexler.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. William Stiles III, a Urological Surgeon, Osteopathic Physician and Doctor of Natural Medicine, has joined the Medical Advisory Board.

“With over two decades of experience as an Osteopathic Physician and a distinguished career in Urologic Surgery, I am dedicated to pioneering the future of medicine through precision wellness,” said Stiles. “My approach integrates advanced data analytics to meticulously assess metabolic functions, enabling tailored strategies that address nutrition, gut health, and hormone optimization.”

Dr. Stiles specializes in crafting personalized health plans that address the unique needs of each individual. By combining deep medical knowledge with a holistic understanding of wellness, they help patients achieve significant, lasting improvements in their health and quality of life.

Respected by peers and praised by patients, Dr. Stiles is committed to pushing the boundaries of what's possible in personal health optimization. Their practice offers a rare blend of scientific rigor and compassionate care, making even the most ambitious health goals attainable.

For those seeking a truly transformative health experience guided by seasoned expertise, Dr. Stiles provides the knowledge, tools, and support to turn aspirations into reality.

Dr. William Hayes, a Flight Surgeon in the U.S. Air Force, joins the Medical Advisory Board for Alzheimer's Treatment Centers of America.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. William Hayes II, a Family Medicine / Hyperbaric Medicine Physician, has joined the Medical Advisory Board. Hayes is a dual board-certified physician with an extensive background in Aerospace Medicine, as well as leadership roles and clinical practice of wound care utilized in the setting of Hyperbaric Medicine.

“My wife and I are both passionate about the effects of Alzheimer's Disease as my father lived in our home with us for the last 15 years of his life,” shared Hayes. “We intimately understand the patient-side of this grueling disease as it progressively strips away the brilliant man that was my greatest friend and advocate throughout my life. I have also seen (in my patients) how hyperbaric medicine can cause a great awakening in the Alzheimer's patient. I can only imagine what can be done under the care of ATCA.”

“I am truly honored and excited to fully accept your offer to join the Medical Advisory Board position. This opportunity is the ‘unicorn’ opportunity that I have been waiting for,” continued Dr. Hayes.

Renowned Physician Pankaj Gupta, MD, MBA is championing health equity with an innovative approach.

Dr. Gupta, a distinguished figure in the healthcare industry, is making waves with his multifaceted roles as a visionary leader and innovator. With a wealth of experience spanning over two decades, Dr. Gupta has established himself as a trailblazer in managed care, focusing on patient-centric solutions and advancing health equity.

As the Founder and CEO of EMDEE, member of the Medical Advisory Board at Alzheimer's Treatment Centers of America, and National Medicare Advantage Medical Director of Clinical Innovation at Optum, Dr. Gupta spearheads initiatives aimed at improving healthcare delivery and outcomes.

His dedication to putting patients first led him to found EQUITAAS, a nonprofit organization committed to advancing health equity. Health equity, a cornerstone of Dr. Gupta's mission, ensures that everyone has equal access to quality care, irrespective of socio-economic factors.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. Mark Rosenbloom (Tiger 21, LifeForce Medical Institute) has joined the Advisory Board of Alzheimer's Treatment Centers of America.

“Dr. Mark Rosenbloom brings decades of experience in root cause analysis as it relates to longevity which also has positive implications for our Alzheimer's disease and dementia patients,” said Greg Buckley, CEO of Alzheimer's Treatment Centers of America. “Mark can suggest even more incredible tools to add value to ATCA's treatment protocols.”

“I am all about anti-aging and performance when it comes to medicine,” adds Dr. Mark Rosenbloom. “When I founded LifeForce, I knew I was involved with precision medicine that has now become my purpose and my passion. When my parents suffered from Alzheimer's in their later years, I was determined to help prevent this disease, evaluate new drugs, and find effective treatments for Alzheimer's disease and dementia.”

Mark Rosenbloom, MD is the Founder and Chief Medical Officer at LIFEFORCE Medical Institute. He began his training at McGill University in Montreal, Canada, completed his MBA at Stanford University, and then fulfilled his dream to become a physician at Northwestern University Feinberg School of Medicine where he ranked #1 in clinical sciences.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. Najib Murr, a Neurologist and Clinical Neurophysiologist, has joined the Medical Advisory Board. Dr. Najib Murr is a neurologist in Hammond, Louisiana and is affiliated with North Oaks Medical Center. He received his medical degree from Lebanese University School of Medicine and has been in practice for more than 20 years. Dr. Najib Murr has expertise in treating Alzheimer's dementia, Parkinson's disease, dementia, among other conditions.

“I am specifically drawn to the epilepsy field because it combines three things that I find very intriguing — our body's nervous system, physics and technology. There are still many ‘unknowns’ when it comes to epilepsy, and I'm passionate about advancing research to improve care for those living with this debilitating condition. My purpose is to help people improve their quality of life, and I look forward to it every day.”

• Medical School — Lebanese University, Faculty of Medical Sciences, Beirut, Lebanon
• Residency — University of Nebraska, Neurology, Omaha, NE
• Fellowship — Vanderbilt University, Clinical Neurophysiology & Epilepsy, Nashville, TN

• American Board of Psychiatry and Neurology in Neurology
• American Board of Psychiatry and Neurology in Clinical Neurophysiology
• American Board of Psychiatry and Neurology in Epilepsy

Alzheimer's Treatment Centers of America is pleased to announce that Keith Hanna has joined our Medical Advisory Board. Dr. Hanna brings tremendous value to our project to roll out ATCA clinics throughout the USA and the world to treat Alzheimer's disease and dementia.

Dr. Keith Hanna is the founder and CEO of IPRD Solutions, an advanced research and software development and deployment group focused on delivering healthcare solutions to the disadvantaged, primarily in Africa. Dr. Hanna embarked on this mission after meeting Bill Gates, founder of the Bill & Melinda Gates Foundation, to discuss advanced technologies and their application in lower-to-middle income countries.

Dr. Hanna's significant experience in bio-medical research, AI, and startup environments has resulted in him advising leading venture groups on emerging technologies related to Alzheimer's screening and monitoring.

Dr. Kenneth Ro, MD is a board-certified Internal Medicine and Emergency Medicine physician with more than 35 years of clinical experience. He is the Founder and CEO of Reclaim Integrative Medicine and creator of the RECLAIM™ Method, a precision medicine approach focused on prevention, performance, longevity, and healthy aging. Dr. Ro is an author, speaker, and healthcare innovator dedicated to helping individuals optimize health through proactive, personalized care. His interests include cognitive health, metabolic health, resilience, and strategies that promote vitality throughout the second half of life.